BUZZ-'Show-stealing' FCF lifts Grifols shares

Shares in Grifols GRLS.MC rise 6% after the Spanish pharmaceutical firm posted better-than-expected Q4 results with "show-stealing" FCF

"Free cash flow steals the show," Berenberg says, referring to end-Q4 FCF of 335 million euros, which substantially beats its forecasts of 114 million euros

J.P. Morgan also notes the key positive was FCF

However, the brokerage says it would be prudent to wait for forward-looking outlook before giving full credit for the FCF improvement

Grifols is set to reveal its 2025 and mid-term outlook later on Thursday

The company also reports Q4 revenues of 1.98 billion euros ($2.07 billion), 4% above Visible Alpha consensus cited by Berenberg, and Q4 EBITDA of 526 million, slightly below the consensus

Shares are on track for best day since mid-December, if gains hold, and second top performer on Madrid's IBEX 35 index .IBEX

($1 = 0.9545 euros)